2-チオウラシル

Thiouracil

HCID 1269845CAS 141-90-2

基本情報

標準SMILES
O=c1cc[nH]c(=S)[nH]1
InChIKey
ZEMGGZBWXRYJHK-UHFFFAOYSA-N
分子式
C4H4N2OS
平均分子量
128.15 g/mol
単同位体質量
128.00443375

概要

Thiouracil can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC).

名称と識別子

優先名称
Thiouracil
IUPAC
2-sulfanylidene-1H-pyrimidin-4-one
現地名
2-チオウラシル
英語名
2-Thiouracil
分子式
C4H4N2OS
分子量
128.15

名称と別名

2-thiouracilThiouracil141-90-2DeracilAntagothyroidAntagothyroilNobilen2-thioxo-2,3-dihydropyrimidin-4(1H)-one2-Mercapto-4-hydroxypyrimidine2-Mercapto-4-pyrimidone4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-6-Thiouracil
名称をさらに表示
2-チオウラシル1,2-ジヒドロ-2-チオキソピリミジン-4(3H)-オンチオウラシル4-ヒドロキシ-2(1H)-ピリミジンチオン2-メルカプト-4-ヒドロキシピリミジン2-メルカプト-4(1H)-ピリミジノンアンタゴチロイル4-ヒドロキシピリミジン-2(1H)-チオン2-チオキソ-1,2,3,4-テトラヒドロピリミジン-4-オンノビレン2-メルカプト-4(3H)-ピリミジノン2,3-ジヒドロ-2-チオキソピリミジン-4(1H)-オン2-チオキソ-1,2-ジヒドロピリミジン-4(3H)-オン2,3-ジヒドロ-2-チオキソ-4(1H)-ピリミジノンアンタゴチロイドデラシル2-チオキソ-2,3-ジヒドロピリミジン-4(1H)-オン2-メルカプト-4(3H)-ピリミドン4-ヒドロキシピリミジン-2(3H)-チオン2-メルカプトピリミジン-4-オールTU2-Mercapto-4-pyriMidinone2-TU
2-Mercapto-4-pyrimidinolUracil, 2-thio-2-sulfanylidene-1H-pyrimidin-4-one4-Hydroxy-2-pyrimidinethiol2,3-Dihydro-2-thioxo-4(1H)-pyrimidinone6-Hydroxy-2-mercaptopyrimidine2-Thio-1,3-pyrimidin-4-one2-Mercapto-4(1H)-pyrimidinone

データベース識別子

CAS
141-90-2
PubChem CID
1269845
DTXSID
DTXSID4021347
ChEMBL
CHEMBL345768
ChEBI
CHEBI:348530
UNII
59X161SCYL
EC Number
205-508-8
Nikkaji
J9.741A

物性

構造計算による物性

XLogP
-0.3
極性表面積
73.2 Ų
水素結合供与体数
2
水素結合受容体数
2
回転可能結合数
0
重原子数
8

実験および物理化学的性質

SpringerMaterials PropertiesDensity
LogP-0.65
OdorODORLESS
TasteBITTER TASTE
Color/Form · 2 件

MINUTE CRYSTALS, PRISMS, OR WHITE OR PALE CREAM-COLORED POWDER

PRISMS FROM WATER OR ALC

Solubility · 2 件

VERY SLIGHTLY SOL IN WATER (1:2000); PRACTICALLY INSOL IN ETHER, ACIDS; READILY SOL IN ALKALINE SOLN

SLIGHTLY SOL IN ALC; SOL IN ANHYD HYDROGEN FLUORIDE

物理化学的性質

融点
300 °C · >300 °C (lit.)
比重(密度)
1.368 · 1.368 (estimate)
屈折率
1.7 · 1.7000 (estimate)
貯蔵温度
30 °C · Store below +30°C.
溶解性
7.9 g/リットル · 7.9g/リットル
外見
微結晶性粉末

化学的性質

化学的特性white to cream fine crystalline powder

安全と法規制

GHS分類

GHS Classification · 6 件

This chemical does not meet GHS hazard criteria for 5.6% (4 of 71) of reports.

Warning

H351 (94.4%): Suspected of causing cancer [Warning Carcinogenicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 71 reports by companies from 5 notifications to the ECHA C&L Inventory.

Danger

危険有害性情報

Regulatory Information · 3 件

Chemical: 4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-

Hazard Traits - Carcinogenicity

4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and Categories · 3 件

Carc. 2 (94.4%)

Acute toxicity (Oral) - Category 5

Acute toxicity (Oral) - Category 5

毒性情報

Natural Pollution SourcesOCCURS IN SEEDS OF BRASSICA, CRUCIFERAE: PURVES, BRIT J EXP PATHOL 22, 241 (1941).
Human Toxicity Excerpts · 5 件

HEMORRHAGE, PETECHIAE, PURPURA.

THIOURACIL CAN INDUCE HEPATIC INJURY. /FROM TABLE/

THESE DRUGS /WHICH INCL THIOURACIL/ HAVE CAUSED NUMEROUS TOXIC SIDE REACTIONS PRINCIPALLY...DRUG FEVER, SKIN ERUPTIONS, & ARTERITIS.

MATERNAL ANTI-THYROID MEDICATION...HAS RESULTED...IN DEVELOPMENT OF FETAL GOITER, & OCCASIONALLY IN HYPOTHYROIDISM IN SOME NEONATE LEADING TO MENTAL RETARDATION. ... JUST OCCASIONALLY, GOITER IN AFFECTED INFANTS MAY OBSTRUCT AIR PASSAGE, & CAUSE RESPIRATORY DISTRESS.

For more Human Toxicity Excerpts (Complete) data for 2-THIOURACIL (6 total), please visit the HSDB record page.

Carcinogen Classification · 5 件

Thiouracil

Group 2B: Possibly carcinogenic to humans

Volume Sup 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, 1987; 440 pages; ISBN 92-832-1411-0 (out of print)

2001

2000

Non-Human Toxicity Excerpts · 5 件

DWARFISM & MENTAL RETARDATION...CAN BE PRODUCED IN RATS BY FEEDING DAMS...THIOURACIL...@ DIETARY LEVEL OF 1,000 PPM.

EIGHTY-ONE MICE OF 3 INBRED STRAINS (A, C57 & I) WERE ADMIN 0.1% THIOURACIL (TU) IN COMMERCIAL DIET FOR PERIODS OF UP TO 80 WK. IN 69 MICE EXAM, THYROIDAL FOLLICULAR CYSTS...FOUND & INTERPRETED BY AUTHORS AS NON-MALIGNANT LESIONS, SINCE THEY REGRESSED FOLLOWING WITHDRAWAL OF THIOURACIL...

OF 52 C STRAIN MICE (40 MALES & 12 FEMALES) ADMIN 0.37% THIOURACIL IN DIET FOR 6 MO FOLLOWED BY 0.5% FOR LIFE, LAST ANIMAL DIED @ 116 WK, & NODULAR HYPERPLASIS OF THYROID OCCURRED IN 28/39 MICE SURVIVING LONGER THAN 10 MO... IN (C57XCBA)F1 FEMALE MICE ADMIN 0.2% IN DIET...FROM 1-29 MO, HEPATOMAS...IN 6/21...ANIMALS.

NODULAR HYPERPLASIA OF THYROID WAS OBSERVED IN STANFORD ALBINO RATS OF BOTH SEXES AFTER ADMIN OF 0.1% THIOURACIL IN DIET FOR UP TO 45 WK. INCIDENCE IN MALES INCR FROM 3/10-11/20 AFTER TREATMENT FOR 29 & 45 WK, RESPECTIVELY. NO INCR...IN FEMALE RATS (3/10, COMPARED WITH 5/15) EXAM AFTER TREATMENT FOR 29 & 38 WK...

For more Non-Human Toxicity Excerpts (Complete) data for 2-THIOURACIL (9 total), please visit the HSDB record page.

Evidence for Carcinogenicity · 1 件

Evaluation: There is inadequate evidence in humans for the carcinogenicity of thiouracil. There is sufficient evidence in experimental animals for the carcinogenicity of thiouracil. Overall evaluation: Thiouracil is probably carcinogenic to humans (Group 2B).

Antidote and Emergency Treatment · 1 件

EARLIEST SIGN OF HYPOTHYROIDISM CALL FOR REDN IN DOSE; IF BY CHANCE THEY HAVE ADVANCED TO POINT OF DISCOMFORT, THYROID HORMONE CAN BE GIVEN TO HASTEN RECOVERY. FULL DOSE OF 120-180 MG DAILY OF THYROID OR EQUIV OF TYHROXINE OR TRIIODOTHYRONINE FOR WK WILL USUALLY SUFFICE. /ANTI-THYROID DRUGS/

安全データ

wgk
3
tsca
TSCA listed
rtecs
YR1575000
hs_code
29335995
risk_code
40-45-20/21/22
化審法
(5)-925

化学と産業

薬理情報

Mechanism of Action · 2 件

ANTITHYROID DRUGS INHIBIT FORMATION OF THYROID HORMONE LARGELY BY INTERFERING WITH INCORPORATION OF IODINE INTO ORGANIC FORM. THIS IMPLIES THAT THEY INTERFERE WITH OXIDN OF IODIDE ION, BUT ELUCIDATION OF DETAILED MECHANISM... HAMPERED BY INCOMPLETE UNDERSTANDING OF IODIDE-OXIDIZING SYSTEM OF...GLAND. /ANTITHYROID DRUGS/

THIOAMIDE DERIV DO NOT HAVE PERMANENT EFFECT UPON THYROID GLAND BUT INHIBIT HORMONE SYNTHESIS & SECRETION UNTIL SPONTANEOUS REMISSION OCCURS DURING COURSE OF DISEASE. /THIOAMIDE DERIV/

Metabolism/Metabolites · 1 件

IN HOMOGENIZED RAT LIVER PREPN FROM FEMALE HOLTZMAN RATS, 28-35% OF THIOURACIL WAS METABOLIZED WITHIN 3 HR. PATHWAY FOR BREAKDOWN OF THIOURACIL WAS SUGGESTED TO BE AS FOLLOWS: URACIL; BETA-UREIDOPROPIONIC ACID, WHICH WAS FURTHER METABOLIZED TO BETA-ALANINE; AMMONIA & CARBON DIOXIDE...

MeSH Pharmacological Classification · 2 件

Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and Excretion · 5 件

DRUG TRANSMISSION TO FETUS: TIME TO APPEAR IN FETUS 10 MIN; TIME TO FETAL/MATERNAL CONCN EQUILIBRIUM 40 MIN; FETAL/MATERNAL CONCN RATIO 1.0 /FROM TABLE/

/IN RATS/ ACCUMULATION OF (35)S LABEL WAS FASTER & OCCURRED TO GREATER EXTENT FROM SMALLER DOSE, SUGGESTING PRESENCE OF SATURABLE TRANSPORT MECHANISM. SIMILAR STUDIES WITH (14)C-THIOURACIL HAVE SHOWN ACCUM OF RADIOACTIVITY IN BOTH MATERNAL & FETAL THYROID TISSUES OF RABBITS...

...WITH BOTH LARGE (39 UMOL) & SMALL (1.2 UMOL) DOSES OF (35)S-THIOURACIL, CONSIDERABLE ACCUM OF BOTH TOTAL RADIOACTIVITY & UNMETABOLIZED (35)S-THIOURACIL OCCURS IN THYROID TISSUE RELATIVE TO PLASMA /IN RATS/.

THIOURACIL IS ABSORBED FROM GI TRACT IN RATS... IN RATS ADMIN 5 MG BY IV INJECTION, 30% OF THIOURACIL...RECOVERED FROM CARCASSES AFTER 3 HR & ONLY TRACES AFTER 24 HR.

For more Absorption, Distribution and Excretion (Complete) data for 2-THIOURACIL (7 total), please visit the HSDB record page.

用途と製造

Uses · 3 件

CHEM INT FOR IOTHIOURACIL SODIUM- AN ANTITHYROID AGENT

MEDICATION

MEDICATION (VET)

U.S. Exports · 2 件

(1972) No Data

(1975) No Data

U.S. Imports · 2 件

(1972) No Data

(1975) No Data

U.S. Production · 2 件

(1974) PROBABLY GREATER THAN 4.54X10+5 GRAMS

(1975) PROBABLY GREATER THAN 4.54X10+5 GRAMS

Methods of Manufacturing · 2 件

CONDENSATION OF ETHYL FORMYLACETATE WITH THIOUREA

PREPD BY CONDENSING ETHYL FORMYLACETATE WITH THIOUREA: WHEELER, LIDDLE, AM CHEM J 40, 550 (1908).

General Manufacturing Information · 2 件

4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-: ACTIVE

THIOAMIDE DERIV USED IN THIS COUNTRY ARE PROPYLTHIOURACIL, METHIMAZOLE, & METHYLTHIOURACIL. THESE DRUGS HAVE REPLACED PARENT COMPD, THIOURACIL, WHICH IS MORE TOXIC.

応用分野

使用2-Thiouracil has been used in the synthesis and characterization of silver colloid and film substrates and their applications in surface-enhanced Raman scattering (SERS)

調製方法

純化方法Crystallise 2-thiouracil from water or EtOH. [Beilstein 24 H 323, 24 I 315, 24 II 171, 24 III/IV 1237.]

サプライヤー50 社

北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
衢州润东化工有限公司0570-8789886 18892685668 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
南京兰亚化工贸易有限公司+86-25-8331-5620 · [email protected]

補足説明

定義ChEBI: A nucleobase analogue that is uracil in which the oxo group at C-2 is replaced by a thioxo group.

関連反応

23 件

関連ノート

読み込み中…